Raymond James Financial Inc. bought a new stake in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 16,866 shares of the company's stock, valued at approximately $325,000.
A number of other hedge funds have also made changes to their positions in the stock. Barclays PLC grew its position in Schrödinger by 421.6% during the third quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after purchasing an additional 86,933 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Schrödinger by 3.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 122,702 shares of the company's stock valued at $2,276,000 after buying an additional 4,403 shares during the period. GAMMA Investing LLC grew its stake in Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after purchasing an additional 1,305 shares in the last quarter. Avanza Fonder AB acquired a new stake in Schrödinger in the fourth quarter valued at approximately $577,000. Finally, Geneos Wealth Management Inc. increased its position in Schrödinger by 15.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company's stock worth $1,157,000 after buying an additional 8,021 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Schrödinger
In other Schrödinger news, insider Karen Akinsanya sold 16,723 shares of the business's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the sale, the insider now directly owns 15,625 shares of the company's stock, valued at approximately $392,031.25. The trade was a 51.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Geoffrey Craig Porges sold 5,491 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares in the company, valued at $599,357.44. This trade represents a 16.62% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 8.60% of the company's stock.
Analysts Set New Price Targets
SDGR has been the subject of several recent analyst reports. Piper Sandler decreased their price objective on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. KeyCorp raised their target price on Schrödinger from $30.00 to $32.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $32.80.
Check Out Our Latest Research Report on SDGR
Schrödinger Price Performance
Shares of Schrödinger stock traded down $1.14 during midday trading on Thursday, hitting $22.79. 410,837 shares of the company were exchanged, compared to its average volume of 841,461. The firm has a 50 day simple moving average of $22.78 and a 200-day simple moving average of $21.89. Schrödinger, Inc. has a 52 week low of $16.60 and a 52 week high of $28.47. The firm has a market cap of $1.66 billion, a P/E ratio of -9.72 and a beta of 1.84.
Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). The firm had revenue of $59.55 million for the quarter, compared to the consensus estimate of $54.60 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company's revenue for the quarter was up 62.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.86) earnings per share. Equities research analysts expect that Schrödinger, Inc. will post -2.37 earnings per share for the current year.
About Schrödinger
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
See Also
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
